Noncoding RNA as an influential epigenetic modulator with promising roles in cancer therapeutics

被引:16
作者
Roy, Laboni [1 ]
Chatterjee, Oishika [1 ]
Bose, Debopriya [1 ]
Roy, Ananya [1 ]
Chatterjee, Subhrangsu [1 ]
机构
[1] Bose Inst, Dept Biophys, Kolkata 700091, India
关键词
ncRNA; lncRNA; miRNA; histone modification; DNA methylation; cancer; BREAST-CANCER; S-ADENOSYLMETHIONINE; PROSTATE-CANCER; EXPRESSION; LNCRNA; RESISTANCE; PROLIFERATION; GENE; CHEMORESISTANCE; PLURIPOTENCY;
D O I
10.1016/j.drudis.2023.103690
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The epigenetic landscape has an important role in cellular homeostasis and its deregulation leads to cancer. Noncoding (nc)RNA networks function as major regulators of cellular epigenetic hallmarks via regulation of vital processes, such as histone modification and DNA methylation. They are integral intracellular components affecting multiple oncogenic pathways. Thus, it is important to elucidate the effects of ncRNA networks on epigenetic programming that lead to the initiation and progression of cancer. In this review, we summarize the effects of epigenetic modification influenced by ncRNA networks and crosstalk between diverse classes of ncRNA, which could aid the development of patient-specific cancer therapeutics targeting ncRNAs, thereby altering cellular epigenetics.
引用
收藏
页数:15
相关论文
共 133 条
[11]   LncRNA UCA1, Upregulated in CRC Biopsies and Downregulated in Serum Exosomes, Controls mRNA Expression by RNA-RNA Interactions [J].
Barbagallo, Cristina ;
Brex, Duilia ;
Caponnetto, Angela ;
Cimigliaro, Matilde ;
Scalia, Marina ;
Magnano, Antonio ;
Caltabiano, Rosario ;
Barbagallo, Davide ;
Biondi, Antonio ;
Cappellani, Alessandro ;
Basile, Francesco ;
Di Pietro, Cinzia ;
Purrello, Michele ;
Ragusa, Marco .
MOLECULAR THERAPY-NUCLEIC ACIDS, 2018, 12 :229-241
[12]   Oncometabolites-A Link between Cancer Cells and Tumor Microenvironment [J].
Baryla, Maksymilian ;
Semeniuk-Wojtas, Aleksandra ;
Rog, Letycja ;
Kraj, Leszek ;
Malyszko, Maciej ;
Stec, Rafal .
BIOLOGY-BASEL, 2022, 11 (02)
[13]   Phase I study of MRX34, a liposomal miR-34a mimic, administered twice weekly in patients with advanced solid tumors [J].
Beg, Muhammad S. ;
Brenner, Andrew J. ;
Sachdev, Jasgit ;
Borad, Mitesh ;
Kang, Yoon-Koo ;
Stoudemire, Jay ;
Smith, Susan ;
Bader, Andreas G. ;
Kim, Sinil ;
Hong, David S. .
INVESTIGATIONAL NEW DRUGS, 2017, 35 (02) :180-188
[14]   LncRNAs as Chromatin Regulators in Cancer: From Molecular Function to Clinical Potential [J].
Begolli, Rodiola ;
Sideris, Nikos ;
Giakountis, Antonis .
CANCERS, 2019, 11 (10)
[15]   Ultraconserved elements in the human genome [J].
Bejerano, G ;
Pheasant, M ;
Makunin, I ;
Stephen, S ;
Kent, WJ ;
Mattick, JS ;
Haussler, D .
SCIENCE, 2004, 304 (5675) :1321-1325
[16]   MALAT1: An Epigenetic Regulator of Inflammation in Diabetic Retinopathy [J].
Biswas, Saumik ;
Thomas, Anu Alice ;
Chen, Shali ;
Aref-Eshghi, Erfan ;
Feng, Biao ;
Gonder, John ;
Sadikovic, Bekim ;
Chakrabarti, Subrata .
SCIENTIFIC REPORTS, 2018, 8
[17]   Antisense lncRNA Transcription Mediates DNA Demethylation to Drive Stochastic Protocadherin α Promoter Choice [J].
Canzio, Daniele ;
Nwakeze, Chiamaka L. ;
Horta, Adan ;
Rajkumar, Sandy M. ;
Coffey, Eliot L. ;
Duffy, Erin E. ;
Duffie, Rachel ;
Monahan, Kevin ;
O'Keeffe, Sean ;
Simon, Matthew D. ;
Lomvardas, Stavros ;
Maniatis, Tom .
CELL, 2019, 177 (03) :639-+
[18]   Therapeutic advances of miRNAs: A preclinical and clinical update [J].
Chakraborty, Chiranjib ;
Sharma, Ashish Ranjan ;
Sharma, Garima ;
Lee, Sang-Soo .
JOURNAL OF ADVANCED RESEARCH, 2021, 28 :127-138
[19]   Biological function and molecular mechanism of piRNA in cancer [J].
Chalbatani, Ghanbar Mahmoodi ;
Dana, Hassan ;
Memari, Feridon ;
Gharagozlou, Elahe ;
Ashjaei, Shirin ;
Kheirandish, Peyman ;
Marmari, Vahid ;
Mahmoudzadeh, Habibollah ;
Mozayani, Farnaz ;
Maleki, Ali Reza ;
Sadeghian, Ehsan ;
Nia, Elham Zainali ;
Miri, Seyed Rohollah ;
Nia, Neda Zainali ;
Rezaeian, Omid ;
Eskandary, Anahita ;
Razavi, Narges ;
Shirkhoda, Mohammad ;
Rouzbahani, Fatemeh Nouri .
PRACTICAL LABORATORY MEDICINE, 2019, 13
[20]   MiR-137 Suppresses Triple-Negative Breast Cancer Stemness and Tumorigenesis by Perturbing BCL11A-DNMT1 Interaction [J].
Chen, Feiyu ;
Luo, Na ;
Hu, Yu ;
Li, Xin ;
Zhang, Kejing .
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2018, 47 (05) :2147-2158